Company intelligence / Profile preview

Data Telesis

San Diego, California, United Statesm.economictimes.com ↗

Ownership: Private
Development stage: Other

Overview

Telesis Bio develops and commercializes automated platforms for high-fidelity, on-demand DNA and mRNA synthesis. Their technologies accelerate workflows in vaccine development, precision immunotherapy, antibody engineering, cell & gene therapy R&D, and synthetic biology applications. The company’s solutions are used by leading biopharma companies and academic institutions to reduce time-to-result by up to 90% compared to traditional outsourcing methods. No direct clinical results as the company is a technology provider.

Modalities: DNA synthesismRNA-based drugsGene therapyAntibody (enabling discovery)Cell therapy (enabling discovery)Vaccine (enabling discovery)
Industry: Non-Drug Biotech

Partnerships

Beckman CoulterAvantor distribution partnership

Beyond the preview

Go deeper on Data Telesis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Data Telesis.

Explore the full profile